MarketCap
The Scotts Miracle-Gro Company SMG
$ 60.94
0.71%
Facebook
X
Telegram
The Scotts Miracle-Gro Company Balance Sheet 2025-2007 | SMG
Brief overview of The Scotts Miracle-Gro Company's balance sheet strength
Balance sheet changes are traced across five available annual reports between 2021 and 2025.
Across five reporting periods, assets decreased -42.9%, from $4.8 billion to $2.7 billion, producing a negative trend.
Funding shifted toward liabilities: they gained -18.1%, compared with -42.9% for assets.
Negative shareholders' equity signals an accumulated net asset deficit and calls for particular caution.
The cash reserve occupies 1.3% of the balance sheet, previously 5.1%. It is one marker of short-term resilience.
Accumulated earnings ended at $294.7 million, a change of -81.6%. They remain an important part of the capital base.
Overall picture
Taken together, The Scotts Miracle-Gro Company's balance sheet indicators point to elevated risk. Asset growth does not offset weak funding sources.
Annual Balance Sheet The Scotts Miracle-Gro Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
2.08 B | 2.18 B | 2.6 B | 2.82 B | 2.06 B | 1.49 B | 1.63 B | 1.98 B | 1.28 B | 1.27 B | 1.09 B | 695 M | 441 M | 651 M | 664 M | 544 M | 740 M | - | - |
Long Term Debt |
2.05 B | 2.17 B | 2.56 B | 2.83 B | 2.24 B | 1.46 B | 1.52 B | 1.88 B | 1.26 B | 1.13 B | 1.03 B | 692 M | 478 M | 781 M | 792 M | 437 M | 650 M | - | - |
Long Term Debt Current |
71.6 M | 75.3 M | 76.4 M | 76.2 M | 66.4 M | 47.5 M | 128 M | 133 M | 143 M | 185 M | 135 M | 91.9 M | 92.4 M | 1.5 M | 3.2 M | 195 M | 160 M | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | 1.68 B | 2.08 B | 1.54 B | 1.48 B | 1.28 B | 946 M | 717 M | 1.04 B | 1.02 B | - | - | - | - |
Total Current Liabilities |
740 M | 750 M | 774 M | 964 M | 1.14 B | 950 M | 620 M | 613 M | 544 M | 593 M | 613 M | 545 M | 510 M | 434 M | 469 M | 737 M | 757 M | - | - |
Total Liabilities |
3.1 B | 3.26 B | 3.68 B | 4.15 B | 3.79 B | 2.68 B | 2.31 B | 2.69 B | 2.09 B | 2.07 B | 1.89 B | 1.49 B | 1.23 B | 1.47 B | 1.49 B | 1.4 B | 1.64 B | - | - |
Retained Earnings |
295 M | 304 M | 491 M | 1.02 B | 1.61 B | 1.24 B | 1.27 B | 920 M | 978 M | 882 M | 684 M | 637 M | 703 M | 630 M | 599 M | 500 M | 338 M | - | - |
Total Assets |
2.74 B | 2.87 B | 3.41 B | 4.3 B | 4.8 B | 3.38 B | 3.03 B | 3.05 B | 2.75 B | 2.81 B | 2.53 B | 2.06 B | 1.94 B | 2.07 B | 2.05 B | 2.16 B | 2.22 B | - | - |
Cash and Cash Equivalents |
36.6 M | 71.6 M | 31.9 M | 86.8 M | 244 M | 16.6 M | 18.8 M | 33.9 M | 120 M | 28.6 M | 50.8 M | 89.3 M | 130 M | 132 M | 131 M | 88.1 M | 70.6 M | 83.7 M | 67.9 M |
Book Value |
-358 M | -391 M | -267 M | 148 M | 1.01 B | 703 M | 723 M | 360 M | 662 M | 734 M | 633 M | 567 M | 710 M | 602 M | 560 M | 764 M | 584 M | - | - |
Total Shareholders Equity |
-358 M | -391 M | -267 M | 148 M | 1.01 B | 703 M | 719 M | 355 M | 649 M | 715 M | 621 M | 554 M | 710 M | 602 M | 560 M | 764 M | 584 M | 437 M | 479 M |
All numbers in USD currency
Quarterly Balance Sheet The Scotts Miracle-Gro Company
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
1.84 B | 2.07 B | 2.25 B | 2.25 B | 2.05 B | 2.14 B | 2.49 B | 2.64 B | 2.17 B | 2.44 B | 2.76 B | 2.97 B | 2.56 B | 2.63 B | 3.14 B | 3.19 B | 2.83 B | 3.16 B | 3.35 B | 1.98 B | 2.24 B | 2.13 B | 2.24 B | - | 1.46 B | 1.46 B | 1.46 B | 1.97 B | 1.52 B | 1.52 B | 1.97 B | 2.19 B | 1.88 B | 1.88 B | 2.19 B | 1.7 B | 1.26 B | 1.26 B | 1.7 B | 1.65 B | 1.03 B | 1.13 B | 1.68 B | - | 1.02 B | 1.02 B | 1.03 B | 1.13 B | 692 M | 692 M | 1.13 B | 652 M | 478 M | 478 M | 652 M | 982 M | 781 M | 781 M | 982 M | 1.03 B | 792 M | 792 M | 1.03 B | 490 M |
Total Liabilities |
3.38 B | 3.7 B | 3.53 B | 3.53 B | 3.1 B | 3.26 B | 3.83 B | 3.65 B | 3.26 B | 3.64 B | 4.18 B | 4.1 B | 3.68 B | 4.32 B | 4.85 B | 4.47 B | 4.15 B | 4.58 B | 5.23 B | 3.32 B | 3.79 B | 3.5 B | 3.79 B | - | 2.68 B | 2.68 B | 2.68 B | 2.83 B | 2.31 B | 2.31 B | 2.83 B | 2.97 B | 2.69 B | 2.69 B | 2.97 B | 2.4 B | 2.09 B | 2.09 B | 2.4 B | 2.42 B | 2.02 B | 2.07 B | 2.47 B | - | 1.89 B | 1.89 B | 1.89 B | 1.8 B | 1.49 B | 1.49 B | 1.8 B | 1.54 B | 1.23 B | 1.23 B | 1.54 B | 1.61 B | 1.47 B | 1.47 B | 1.61 B | 1.7 B | 1.49 B | 1.49 B | 1.7 B | 1.69 B |
Retained Earnings |
404 M | 331 M | 131 M | 131 M | 295 M | 485 M | 374 M | 196 M | 304 M | 586 M | 492 M | 372 M | 491 M | 997 M | 990 M | 918 M | 1.02 B | 1.28 B | 1.76 B | 1.22 B | 1.61 B | 1.69 B | 1.61 B | - | 1.24 B | 1.24 B | 1.24 B | 1.17 B | 1.27 B | 1.27 B | 1.17 B | 835 M | 920 M | 920 M | 835 M | 926 M | 978 M | 978 M | 926 M | 786 M | 882 M | 882 M | 786 M | - | 684 M | 684 M | 684 M | 535 M | 637 M | 637 M | 535 M | 610 M | 703 M | 703 M | 610 M | 542 M | 630 M | 630 M | 542 M | 512 M | 599 M | 599 M | 512 M | 549 M |
Total Assets |
3.17 B | 3.41 B | 3.03 B | 3.03 B | 2.74 B | 3.09 B | 3.54 B | 3.17 B | 2.87 B | 3.49 B | 3.92 B | 3.72 B | 3.41 B | 4.45 B | 4.99 B | 4.53 B | 4.3 B | 4.99 B | 6.21 B | 4 B | 4.8 B | 4.62 B | 4.8 B | - | 3.38 B | 3.38 B | 3.38 B | 3.46 B | 3.03 B | 3.03 B | 3.46 B | 3.23 B | 3.05 B | 3.05 B | 3.23 B | 2.91 B | 2.75 B | 2.75 B | 2.91 B | 3.01 B | 2.76 B | 2.8 B | 3.06 B | - | 2.53 B | 2.53 B | 2.53 B | 2.27 B | 2.06 B | 2.06 B | 2.27 B | 2.16 B | 1.94 B | 1.94 B | 2.16 B | 2.13 B | 2.07 B | 2.07 B | 2.13 B | 2.16 B | 2.05 B | 2.05 B | 2.16 B | 2.52 B |
Cash and Cash Equivalents |
27.7 M | 6.2 M | 8.3 M | 8.3 M | 32.8 M | 51.1 M | 16.9 M | 5.7 M | 71.6 M | 280 M | 65.1 M | 10.4 M | 31.9 M | 27.4 M | 25 M | 25.6 M | 86.8 M | 27.8 M | 17.1 M | 21.5 M | 244 M | 58.3 M | 244 M | - | 16.6 M | 16.6 M | 16.6 M | 27.4 M | 18.8 M | 18.8 M | 27.4 M | 22.6 M | 33.9 M | 33.9 M | 22.6 M | 54.5 M | 120 M | 120 M | 54.5 M | 73.1 M | 28.6 M | 50.1 M | 88.7 M | - | 50.8 M | 71.4 M | 71.4 M | 130 M | 64.9 M | 89.3 M | 130 M | 125 M | 130 M | 130 M | 125 M | 116 M | 132 M | 132 M | 116 M | 128 M | 131 M | 131 M | 128 M | 78.7 M |
Book Value |
-209 M | -286 M | -501 M | -501 M | -358 M | -171 M | -290 M | -480 M | -391 M | -146 M | -251 M | -385 M | -267 M | 135 M | 138 M | 59.5 M | 148 M | 418 M | 975 M | 679 M | 1.01 B | 1.12 B | 1.01 B | - | 703 M | 703 M | 703 M | 629 M | 723 M | 723 M | 629 M | 253 M | 360 M | 360 M | 253 M | 508 M | 662 M | 662 M | 508 M | 592 M | 734 M | 734 M | 592 M | - | 633 M | 633 M | 633 M | 461 M | 567 M | 567 M | 461 M | 621 M | 710 M | 710 M | 621 M | 514 M | 602 M | 602 M | 514 M | 464 M | 560 M | 560 M | 464 M | 835 M |
Total Shareholders Equity |
-209 M | -286 M | -501 M | -501 M | -358 M | -171 M | -290 M | -480 M | -391 M | -146 M | -251 M | -385 M | -267 M | 135 M | 138 M | 59.5 M | 148 M | 418 M | 975 M | 832 M | 1.01 B | 1.12 B | 941 M | - | 697 M | 697 M | 697 M | 625 M | 719 M | 719 M | 625 M | 248 M | 355 M | 355 M | 248 M | 503 M | 649 M | 649 M | 503 M | 580 M | 715 M | 715 M | 580 M | - | 621 M | 621 M | 621 M | 447 M | 554 M | 554 M | 447 M | 621 M | 710 M | 710 M | 621 M | 514 M | 602 M | 602 M | 514 M | 464 M | 560 M | 560 M | 464 M | 835 M |
All numbers in USD currency
Balance Sheet is a fundamental financial report of The Scotts Miracle-Gro Company, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Agricultural inputs
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
China Green Agriculture
CGA
|
- | 0.51 % | $ 27.6 M |  China |
 |
Акрон
AKRN
|
- | - | - |  Russia |
 |
American Vanguard Corporation
AVD
|
$ 2.12 | 1.41 % | $ 60.3 M |  USA |
 |
CF Industries Holdings
CF
|
$ 118.3 | 1.59 % | $ 19.2 B | USA |
 |
ICL Group Ltd
ICL
|
$ 5.55 | 2.97 % | $ 7.16 B |  Israel |
 |
FMC Corporation
FMC
|
$ 10.15 | 0.34 % | $ 1.27 B | USA |
 |
Marrone Bio Innovations
MBII
|
- | -5.9 % | $ 180 M | USA |
 |
Yield10 Bioscience
YTEN
|
- | 15.32 % | $ 46.6 M | USA |
 |
ФосАгро
PHOR
|
- | - | - | Russia |
 |
The Mosaic Company
MOS
|
$ 21.61 | 0.07 % | $ 6.86 B | USA |
 |
Bioceres Crop Solutions Corp.
BIOX
|
$ 0.45 | 4.42 % | $ 28.5 M |  Argentina |
 |
Corteva
CTVA
|
$ 76.68 | 1.17 % | $ 52.1 B | USA |
 |
Origin Agritech Limited
SEED
|
$ 1.03 | 0.37 % | $ 7.72 M | China |
 |
Arcadia Biosciences
RKDA
|
$ 0.62 | 9.6 % | $ 848 K | USA |
 |
CVR Partners, LP
UAN
|
$ 123.5 | 4.09 % | $ 1.31 B | USA |
 |
Intrepid Potash
IPI
|
$ 36.62 | 1.78 % | $ 477 M | USA |
 |
Nutrien Ltd.
NTR
|
$ 68.24 | 1.14 % | $ 33.2 B |  Canada |